Carnegie Investment Counsel’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-8,400
Closed -$234K 519
2021
Q3
$234K Sell
8,400
-1,400
-14% -$39K 0.01% 434
2021
Q2
$290K Sell
9,800
-4,150
-30% -$123K 0.01% 400
2021
Q1
$390K Sell
13,950
-1,300
-9% -$36.3K 0.02% 345
2020
Q4
$432K Buy
+15,250
New +$432K 0.02% 317